Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.

Strollo R, Vinci C, Napoli N, Fioriti E, Maddaloni E, Åkerman L, Casas R, Pozzilli P, Ludvigsson J, Nissim A.

Diabetes Metab Res Rev. 2019 May;35(4):e3132. doi: 10.1002/dmrr.3132. Epub 2019 Feb 18.

PMID:
30693639
2.

Oxidative stress in autoimmune rheumatic diseases.

Smallwood MJ, Nissim A, Knight AR, Whiteman M, Haigh R, Winyard PG.

Free Radic Biol Med. 2018 Sep;125:3-14. doi: 10.1016/j.freeradbiomed.2018.05.086. Epub 2018 May 30. Review.

PMID:
29859343
3.

Graphene Oxide Sheets Combine into Conductive Coatings by Direct Oxidative Electropolymerization.

Halevy S, Bochlin Y, Kadosh Y, Kaplan A, Avraham H, Nissim A, Ben Hamo R, Ohaion-Raz T, Korin E, Bettelheim A.

Sci Rep. 2017 Jul 10;7(1):4987. doi: 10.1038/s41598-017-05269-1.

4.

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.

Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A.

Diabetologia. 2017 Aug;60(8):1467-1474. doi: 10.1007/s00125-017-4296-1. Epub 2017 May 20.

5.

Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.

Rizzo P, Pitocco D, Zaccardi F, Di Stasio E, Strollo R, Rizzi A, Scavone G, Costantini F, Galli M, Tinelli G, Flex A, Caputo S, Pozzilli P, Landolfi R, Ghirlanda G, Nissim A.

Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2839. Epub 2016 Oct 5.

PMID:
27454862
6.

Progress and clinical potential of antibody-targeted therapy for arthritic damage.

Hughes C, Nissim A.

Expert Rev Proteomics. 2016 Jun;13(6):539-43. doi: 10.1080/14789450.2016.1188008. Review.

PMID:
27258782
7.

In vivo optical imaging of early osteoarthritis using an antibody specific to damaged arthritic cartilage.

Lim NH, Vincent TL, Nissim A.

Arthritis Res Ther. 2015 Dec 25;17:376. doi: 10.1186/s13075-015-0898-5.

8.

Antibodies to post-translationally modified insulin in type 1 diabetes.

Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P, Nissim A.

Diabetologia. 2015 Dec;58(12):2851-60. doi: 10.1007/s00125-015-3746-x. Epub 2015 Sep 8.

PMID:
26350612
9.

The "Tree-in-Bud" Pattern on Chest CT: Radiologic and Microbiologic Correlation.

Shimon G, Yonit WW, Gabriel I, Naama BR, Nissim A.

Lung. 2015 Oct;193(5):823-9. doi: 10.1007/s00408-015-9759-x. Epub 2015 Jul 9.

PMID:
26156310
10.

Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency.

Hughes C, Sette A, Seed M, D'Acquisto F, Manzo A, Vincent TL, Lim NH, Nissim A.

Arthritis Res Ther. 2014 Jul 16;16(4):R151. doi: 10.1186/ar4613.

11.

Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases.

Ryan BJ, Nissim A, Winyard PG.

Redox Biol. 2014 May 28;2:715-24. doi: 10.1016/j.redox.2014.05.004. eCollection 2014. Review.

12.

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.

Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu CH, Dobson R, Disanto G, Norgren N, Nissim A, Kappos L, Hurlbert J, Yong VW, Giovannoni G, Casha S.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):273-9. doi: 10.1136/jnnp-2013-307454. Epub 2014 Jun 16.

PMID:
24935984
13.

Autoantibodies to posttranslational modifications in rheumatoid arthritis.

Burska AN, Hunt L, Boissinot M, Strollo R, Ryan BJ, Vital E, Nissim A, Winyard PG, Emery P, Ponchel F.

Mediators Inflamm. 2014;2014:492873. doi: 10.1155/2014/492873. Epub 2014 Mar 23. Review.

14.

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU, Regeniter A, Lindberg RL, Kappos L, Leppert D, Petzold A, Giovannoni G, Kuhle J.

PLoS One. 2013 Sep 20;8(9):e75091. doi: 10.1371/journal.pone.0075091. eCollection 2013.

15.

Structural guided scaffold phage display libraries as a source of bio-therapeutics.

Man YK, DiCara D, Chan N, Vessillier S, Mather SJ, Rowe ML, Howard MJ, Marshall JF, Nissim A.

PLoS One. 2013 Aug 9;8(8):e70452. doi: 10.1371/journal.pone.0070452. eCollection 2013.

16.

Epidemiological study of an outbreak of Norovirus in a rest home in Italy.

Di Giannatale E, Alessiani A, Sauro F, Sbraccia F, Croce G, Nissim A, Carnevale A, Migliorati G.

Vet Ital. 2013 Apr-Jun;49(2):175-80.

17.

Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.

Strollo R, Ponchel F, Malmström V, Rizzo P, Bombardieri M, Wenham CY, Landy R, Perret D, Watt F, Corrigall VM, Winyard PG, Pozzilli P, Conaghan PG, Panayi GS, Klareskog L, Emery P, Nissim A.

Arthritis Rheum. 2013 Jul;65(7):1702-12. doi: 10.1002/art.37964.

18.

A comparative study of CSF neurofilament light and heavy chain protein in MS.

Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, Nissim A, Malaspina A, Leppert D, Giovannoni G, Kappos L.

Mult Scler. 2013 Oct;19(12):1597-603. doi: 10.1177/1352458513482374. Epub 2013 Mar 25.

PMID:
23529999
19.

Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens.

Eggleton P, Nissim A, Ryan BJ, Whiteman M, Winyard PG.

Free Radic Biol Med. 2013 Apr;57:79-91. doi: 10.1016/j.freeradbiomed.2012.11.006. Epub 2012 Dec 12.

PMID:
23246567
20.

HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.

Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, Napoli N, Palermo A, Buzzetti R, Pozzilli P, Nissim A.

Diabetologia. 2013 Mar;56(3):563-72. doi: 10.1007/s00125-012-2780-1. Epub 2012 Nov 19.

PMID:
23160643
21.

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.

Wythe SE, DiCara D, Taher TE, Finucane CM, Jones R, Bombardieri M, Man YK, Nissim A, Mather SJ, Chernajovsky Y, Pitzalis C.

Ann Rheum Dis. 2013 Jan;72(1):129-35. doi: 10.1136/annrheumdis-2012-201457. Epub 2012 Jul 27.

22.

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.

Kamperidis P, Kamalati T, Ferrari M, Jones M, Garrood T, Smith MD, Diez-Posada S, Hughes C, Finucane C, Mather S, Nissim A, George AJ, Pitzalis C.

Arthritis Rheum. 2011 Dec;63(12):3758-67. doi: 10.1002/art.30650.

23.

Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease.

Winyard PG, Ryan B, Eggleton P, Nissim A, Taylor E, Lo Faro ML, Burkholz T, Szabó-Taylor KE, Fox B, Viner N, Haigh RC, Benjamin N, Jones AM, Whiteman M.

Biochem Soc Trans. 2011 Oct;39(5):1226-32. doi: 10.1042/BST0391226. Review.

PMID:
21936794
24.

Involvement of autoimmunity in the pathogenesis of aggressive periodontitis.

Hendler A, Mulli TK, Hughes FJ, Perrett D, Bombardieri M, Houri-Haddad Y, Weiss EI, Nissim A.

J Dent Res. 2010 Dec;89(12):1389-94. doi: 10.1177/0022034510381903. Epub 2010 Oct 12.

PMID:
20940360
25.

Human single-chain variable fragment that specifically targets arthritic cartilage.

Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil N, Marrelli A, Gould D, Subang C, Al-Kashi A, De Bari C, Winyard P, Chernajovsky Y, Nissim A.

Arthritis Rheum. 2010 Apr;62(4):1007-16. doi: 10.1002/art.27346.

26.

Treatment of chest wall implosion injuries without thoracotomy: technique and clinical outcomes.

Solberg BD, Moon CN, Nissim AA, Wilson MT, Margulies DR.

J Trauma. 2009 Jul;67(1):8-13; discussion 13. doi: 10.1097/TA.0b013e3181a8b3be.

PMID:
19590301
27.

Historical development of monoclonal antibody therapeutics.

Nissim A, Chernajovsky Y.

Handb Exp Pharmacol. 2008;(181):3-18. Review.

PMID:
18071939
28.

Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.

Nissim A, Winyard PG, Corrigall V, Fatah R, Perrett D, Panayi G, Chernajovsky Y.

Arthritis Rheum. 2005 Dec;52(12):3829-38.

29.

The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation.

Inglis JJ, Nissim A, Lees DM, Hunt SP, Chernajovsky Y, Kidd BL.

Arthritis Res Ther. 2005;7(4):R807-16. Epub 2005 Apr 12.

30.

Methods for targeting biologicals to specific disease sites.

Nissim A, Gofur Y, Vessillier S, Adams G, Chernajovsky Y.

Trends Mol Med. 2004 Jun;10(6):269-74. Review.

PMID:
15177191
31.

A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival.

Cohen-Saidon C, Nechushtan H, Kahlon S, Livni N, Nissim A, Razin E.

Blood. 2003 Oct 1;102(7):2506-12. Epub 2003 Jun 5. Erratum in: Blood. 2015 Apr 9;125(15):2451.

32.
33.

Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library.

Flores-Flores C, Nissim A, Shochat S, Soreq H.

J Neural Transm Suppl. 2002;(62):165-79.

PMID:
12456061
34.

Single chain antibodies specific for fatty acids derived from a semi-synthetic phage display library.

Gargir A, Ofek I, Meron-Sudai S, Tanamy MG, Kabouridis PS, Nissim A.

Biochim Biophys Acta. 2002 Jan 15;1569(1-3):167-73.

PMID:
11853971
35.

Inhibition of antibody-dependent stimulation of lipoteichoic acid-treated human monocytes and macrophages by polyglycerolphosphate-reactive peptides.

Gargir A, Ofek I, Hasty D, Meron-Sudai S, Tsubery H, Keisari Y, Nissim A.

J Leukoc Biol. 2001 Oct;70(4):537-42.

PMID:
11590189
36.

Generation and epitope mapping of high-affinity scFv to eukaryotic elongation factor 1A by dual application of phage display.

Kjaer S, Wind T, Ravn P, Østergaard M, Clark BF, Nissim A.

Eur J Biochem. 2001 Jun;268(12):3407-15.

37.

Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library.

Vaisman N, Nissim A, Klapper LN, Tirosh B, Yarden Y, Sela M.

Immunol Lett. 2000 Dec 1;75(1):61-7.

PMID:
11163868
38.

Human single-chain Fv fragments specific for natural killer cell receptors from phage display libraries.

Uchanska-Ziegler B, Qiao X, Volz A, Nissim A, Ziegler A.

Methods Mol Biol. 2000;121:219-37. Review. No abstract available.

PMID:
10818729
39.

Antibodies from phage display libraries as immunochemical reagents.

Neri D, Pini A, Nissim A.

Methods Mol Biol. 1998;80:475-500. No abstract available.

PMID:
9664403
40.

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.

Neri D, Carnemolla B, Nissim A, Leprini A, Querzè G, Balza E, Pini A, Tarli L, Halin C, Neri P, Zardi L, Winter G.

Nat Biotechnol. 1997 Nov;15(12):1271-5.

PMID:
9359110
41.

Screening of phage antibody libraries.

Harrison JL, Williams SC, Winter G, Nissim A.

Methods Enzymol. 1996;267:83-109. No abstract available.

PMID:
8743311
42.

Improvement of Aconitum napellus micropropagation by liquid culture on floating membrane rafts.

Watad AA, Kochba M, Nissim A, Gaba V.

Plant Cell Rep. 1995 Mar;14(6):345-8. doi: 10.1007/BF00238594.

PMID:
24185330
43.

Antibody fragments from a 'single pot' phage display library as immunochemical reagents.

Nissim A, Hoogenboom HR, Tomlinson IM, Flynn G, Midgley C, Lane D, Winter G.

EMBO J. 1994 Feb 1;13(3):692-8.

44.

Fine specificity of the IgE interaction with the low and high affinity Fc receptor.

Nissim A, Schwarzbaum S, Siraganian R, Eshhar Z.

J Immunol. 1993 Feb 15;150(4):1365-74.

PMID:
7679426
45.
46.

The murine 2-5A synthetase locus: three distinct transcripts from two linked genes.

Rutherford MN, Kumar A, Nissim A, Chebath J, Williams BR.

Nucleic Acids Res. 1991 Apr 25;19(8):1917-24.

47.

Localization of the Fc epsilon RI binding site to the third constant domain of IgE.

Nissim A, Eshhar Z.

Int Arch Allergy Appl Immunol. 1991;94(1-4):93-5. No abstract available.

PMID:
1834586
48.
49.

A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication.

Coccia EM, Romeo G, Nissim A, Marziali G, Albertini R, Affabris E, Battistini A, Fiorucci G, Orsatti R, Rossi GB, et al.

Virology. 1990 Nov;179(1):228-33.

PMID:
2171206
50.

Mapping of murine IgE epitopes involved in IgE-Fc epsilon receptor interactions.

Schwarzbaum S, Nissim A, Alkalay I, Ghozi MC, Schindler DG, Bergman Y, Eshhar Z.

Eur J Immunol. 1989 Jun;19(6):1015-23.

PMID:
2473907

Supplemental Content

Loading ...
Support Center